208 related articles for article (PubMed ID: 36798768)
1. Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer.
Jin Z; Peng F; Zhang C; Tao S; Xu D; Zhu Z
Heliyon; 2023 Feb; 9(2):e13195. PubMed ID: 36798768
[TBL] [Abstract][Full Text] [Related]
2. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
Tomita Y; Yuno A; Tsukamoto H; Senju S; Kuroda Y; Hirayama M; Irie A; Kawahara K; Yatsuda J; Hamada A; Jono H; Yoshida K; Tsunoda T; Kohrogi H; Yoshitake Y; Nakamura Y; Shinohara M; Nishimura Y
Clin Cancer Res; 2013 Aug; 19(16):4508-20. PubMed ID: 23714729
[TBL] [Abstract][Full Text] [Related]
3. Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis.
Shi C; Huang D; Lu N; Chen D; Zhang M; Yan Y; Deng L; Lu Q; Lu H; Luo S
Oncotarget; 2016 May; 7(18):26206-19. PubMed ID: 27036048
[TBL] [Abstract][Full Text] [Related]
4. Roles and mechanisms of Kinesin-6 KIF20A in spindle organization during cell division.
Wu WD; Yu KW; Zhong N; Xiao Y; She ZY
Eur J Cell Biol; 2019 Jun; 98(2-4):74-80. PubMed ID: 30579662
[TBL] [Abstract][Full Text] [Related]
5. Cyclin F and KIF20A, FOXM1 target genes, increase proliferation and invasion of ovarian cancer cells.
Li Y; Guo H; Wang Z; Bu H; Wang S; Wang H; Fang H; Liu Z; Kong B
Exp Cell Res; 2020 Oct; 395(2):112212. PubMed ID: 32771525
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer.
Asahara S; Takeda K; Yamao K; Maguchi H; Yamaue H
J Transl Med; 2013 Nov; 11():291. PubMed ID: 24237633
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of KIF20A, a potential immunotherapeutic target for glioma.
Saito K; Ohta S; Kawakami Y; Yoshida K; Toda M
J Neurooncol; 2017 Mar; 132(1):63-74. PubMed ID: 28070829
[TBL] [Abstract][Full Text] [Related]
8. MKLP2 Is a Motile Kinesin that Transports the Chromosomal Passenger Complex during Anaphase.
Adriaans IE; Hooikaas PJ; Aher A; Vromans MJM; van Es RM; Grigoriev I; Akhmanova A; Lens SMA
Curr Biol; 2020 Jul; 30(13):2628-2637.e9. PubMed ID: 32502404
[TBL] [Abstract][Full Text] [Related]
9. Characterization of KIF20A as a prognostic biomarker and therapeutic target for different subtypes of breast cancer.
Nakamura M; Takano A; Thang PM; Tsevegjav B; Zhu M; Yokose T; Yamashita T; Miyagi Y; Daigo Y
Int J Oncol; 2020 Jul; 57(1):277-288. PubMed ID: 32467984
[TBL] [Abstract][Full Text] [Related]
10. Identification of HLA-A24-restricted novel T Cell epitope peptides derived from P-cadherin and kinesin family member 20A.
Osawa R; Tsunoda T; Yoshimura S; Watanabe T; Miyazawa M; Tani M; Takeda K; Nakagawa H; Nakamura Y; Yamaue H
J Biomed Biotechnol; 2012; 2012():848042. PubMed ID: 22778556
[TBL] [Abstract][Full Text] [Related]
11. Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancer.
Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tomita Y; Tsunoda T; Nakagawa H; Nakamura Y; Baba H; Nishimura Y
Br J Cancer; 2011 Jan; 104(2):300-7. PubMed ID: 21179034
[TBL] [Abstract][Full Text] [Related]
12. FOXM1 regulates radiosensitivity of lung cancer cell partly by upregulating KIF20A.
Xiu G; Sui X; Wang Y; Zhang Z
Eur J Pharmacol; 2018 Aug; 833():79-85. PubMed ID: 29704495
[TBL] [Abstract][Full Text] [Related]
13. KIF20A, highly expressed in immature hematopoietic cells, supports the growth of HL60 cell line.
Morita H; Matsuoka A; Kida JI; Tabata H; Tohyama K; Tohyama Y
Int J Hematol; 2018 Dec; 108(6):607-614. PubMed ID: 30182171
[TBL] [Abstract][Full Text] [Related]
14. FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A.
Yu H; Xu Z; Guo M; Wang W; Zhang W; Liang S; Xu Z; Ye J; Zhu G; Zhang C; Lin J
Cancer Cell Int; 2020 Nov; 20(1):545. PubMed ID: 33292277
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients.
Liu SL; Lin HX; Qiu F; Zhang WJ; Niu CH; Wen W; Sun XQ; Ye LP; Wu XQ; Lin CY; Song LB; Guo L
PLoS One; 2017; 12(1):e0169280. PubMed ID: 28081138
[TBL] [Abstract][Full Text] [Related]
16. Changing places: Chromosomal Passenger Complex relocation in early anaphase.
Hadders MA; Lens SMA
Trends Cell Biol; 2022 Feb; 32(2):165-176. PubMed ID: 34663523
[TBL] [Abstract][Full Text] [Related]
17. Genistein-induced mitotic arrest of gastric cancer cells by downregulating KIF20A, a proteomics study.
Yan GR; Zou FY; Dang BL; Zhang Y; Yu G; Liu X; He QY
Proteomics; 2012 Aug; 12(14):2391-9. PubMed ID: 22887948
[TBL] [Abstract][Full Text] [Related]
18. KIF20A promotes cellular malignant behavior and enhances resistance to chemotherapy in colorectal cancer through regulation of the JAK/STAT3 signaling pathway.
Xiong M; Zhuang K; Luo Y; Lai Q; Luo X; Fang Y; Zhang Y; Li A; Liu S
Aging (Albany NY); 2019 Dec; 11(24):11905-11921. PubMed ID: 31841120
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of the NCCV Cocktail-1 vaccine for refractory pediatric solid tumors: A phase I clinical trial.
Akazawa Y; Hosono A; Yoshikawa T; Kaneda H; Nitani C; Hara J; Kinoshita Y; Kohashi K; Manabe A; Fukutani M; Wakabayashi M; Sato A; Shoda K; Shimomura M; Mizuno S; Nakamoto Y; Nakatsura T
Cancer Sci; 2019 Dec; 110(12):3650-3662. PubMed ID: 31571332
[TBL] [Abstract][Full Text] [Related]
20. Positive expression of KIF20A indicates poor prognosis of glioma patients.
Duan J; Huang W; Shi H
Onco Targets Ther; 2016; 9():6741-6749. PubMed ID: 27843327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
